Literature DB >> 30616819

Luciferase reporter assay for unlocking ligand-mediated signaling of GPCRs.

Hamiyet Unal1.   

Abstract

G protein-coupled receptors (GPCRs) play an active role in numerous cellular processes, from cell proliferation to differentiation, by modulating gene transcription through various signal transduction pathways. Transcriptional regulation coupled to reporter gene expression may be used to study both G protein-dependent and G protein-independent responses activated by GPCR ligands. Reporter genes are typically used to monitor changes in receptor-mediated cellular responses at the transcription/translation level. Genetic reporter assays are based on reporter gene expression in response to activation of specific signaling cascade, followed by monitoring the presence of the reporter protein by directly measuring its enzymatic activity. These optimized genes are expressed under the control of a response element to assess its transcriptional activity that can be readily detected by a luminescent signal. Firefly luciferase gene has been widely used as a genetic reporter that responds rapidly to modulation of a GPCR by agonists or antagonists. Luciferase assays have been successfully developed for deorphanization of GPCRs, high-throughput screening (HTS) applications for drug discovery and deciphering both canonical and non-canonical signaling of numerous GPCRs. The protocol outlined for STAT3-driven luciferase assay could be adapted with appropriate changes to any aspect of GPCR signaling.
© 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Deorphanization; Dual-Glo; GPCR; Ligand discovery; Luciferase; Renilla; Reporter assay; Signal transduction

Mesh:

Substances:

Year:  2018        PMID: 30616819     DOI: 10.1016/bs.mcb.2018.08.001

Source DB:  PubMed          Journal:  Methods Cell Biol        ISSN: 0091-679X            Impact factor:   1.441


  7 in total

1.  Long non-coding RNA 00960 promoted the aggressiveness of lung adenocarcinoma via the miR-124a/SphK1 axis.

Authors:  Zhipeng Ge; Haibo Liu; Tao Ji; Qiaoling Liu; Lulu Zhang; Pengchong Zhu; Liang Li; Liangming Zhu
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

2.  Long non-coding RNA AC012668 suppresses non-alcoholic fatty liver disease by competing for microRNA miR-380-5p with lipoprotein-related protein LRP2.

Authors:  Xiaomeng Chen; Hong Ma; Yan Gao; Ye Jin; Wei Ning; Yue Hou; Jianrong Su
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

3.  Circular RNA circ_0090231 promotes atherosclerosis in vitro by enhancing NLR family pyrin domain containing 3-mediated pyroptosis of endothelial cells.

Authors:  Yishan Ge; Wenwu Liu; Wei Yin; Xuebin Wang; Jie Wang; Xiaoqing Zhu; Shengkai Xu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 4.  Coelenterazine-Dependent Luciferases as a Powerful Analytical Tool for Research and Biomedical Applications.

Authors:  Vasilisa V Krasitskaya; Eugenia E Bashmakova; Ludmila A Frank
Journal:  Int J Mol Sci       Date:  2020-10-10       Impact factor: 5.923

5.  Genetic Polymorphisms in miR-604A>G, miR-938G>A, miR-1302-3C>T and the Risk of Idiopathic Recurrent Pregnancy Loss.

Authors:  Sung-Hwan Cho; Ji-Hyang Kim; Hui-Jeong An; Young-Ran Kim; Eun-Hee Ahn; Jung-Ryeol Lee; Jung-Oh Kim; Jung-Jae Ko; Nam-Keun Kim
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

6.  Serum miR-96-5p is a novel and non-invasive marker of acute myocardial infarction associated with coronary artery disease.

Authors:  Hui Ding; Wen Chen; Xin Chen
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

7.  Long non-coding RNA CRNDE regulates the growth and migration of prostate cancer cells by targeting microRNA-146a-5p.

Authors:  Dewang Fu; Li'e Zang; Zhaowei Li; Chenghui Fan; Huamao Jiang; Tongyi Men
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.